Compare MMYT & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMYT | BIRK |
|---|---|---|
| Founded | 2000 | 1774 |
| Country | India | United Kingdom |
| Employees | N/A | N/A |
| Industry | Transportation Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.9B |
| IPO Year | 2010 | 2023 |
| Metric | MMYT | BIRK |
|---|---|---|
| Price | $63.66 | $37.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $106.33 | $62.69 |
| AVG Volume (30 Days) | 1.6M | ★ 2.9M |
| Earning Date | 01-21-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.10 |
| EPS | 0.53 | ★ 2.19 |
| Revenue | $1,039,337,000.00 | ★ $2,460,904,611.00 |
| Revenue This Year | $17.65 | $14.09 |
| Revenue Next Year | $17.64 | $14.29 |
| P/E Ratio | $117.53 | ★ $17.23 |
| Revenue Growth | 11.07 | ★ 16.22 |
| 52 Week Low | $60.22 | $36.78 |
| 52 Week High | $120.73 | $62.66 |
| Indicator | MMYT | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 30.17 | 36.04 |
| Support Level | $60.22 | $36.78 |
| Resistance Level | $64.09 | $38.68 |
| Average True Range (ATR) | 3.11 | 1.64 |
| MACD | -0.97 | -0.28 |
| Stochastic Oscillator | 17.71 | 9.33 |
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.